pSivida Corp

Press Releases

All Releases
View Summary pSivida Reports Australia/New Zealand Distribution Agreement for ILUVIEN® for DME
Apr 28, 2014
PDF 16.2 KB Add to Briefcase
View Summary pSivida Selected to Present at 2014 Opthalmology Innovation Summit
Apr 23, 2014
PDF 17.0 KB Add to Briefcase
View Summary pSivida Announces September 26, 2014 PDUFA Date for ILUVIEN®
Apr 14, 2014
PDF 15.9 KB Add to Briefcase
View Summary pSivida CEO to Discuss Company's Sustained Release Delivery System for Biologics at Two Upcoming Conferences
Apr 1, 2014
PDF 17.0 KB Add to Briefcase
View Summary pSivida Announces Resubmission of New Drug Application for ILUVIEN®
Mar 27, 2014
PDF 16.1 KB Add to Briefcase
View Summary pSivida Corp. Announces $7.0 Million Investment by RA Capital
Mar 13, 2014
PDF 14.0 KB Add to Briefcase
View Summary pSivida Announces ILUVIEN® for DME Accepted by National Health Service Scotland
Feb 10, 2014
PDF 16.5 KB Add to Briefcase
View Summary pSivida Corp. Reports Second Quarter 2014 Results
Feb 7, 2014
PDF 29.9 KB Add to Briefcase
View Summary pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 11
Feb 6, 2014
PDF 17.3 KB Add to Briefcase
View Summary pSivida CEO to Present at 16th Annual BioCEO & Investor Conference February 12
Feb 6, 2014
PDF 17.3 KB Add to Briefcase
View Summary pSivida Corp Announces Second Quarter 2014 Financial Results Release Date and Conference Call Information
Jan 30, 2014
PDF 16.9 KB Add to Briefcase
View Summary pSivida Corp. Reports First Orders for ILUVIEN® Shipped for U.K. National Health Service Hospitals Less Than Seven Weeks After Final NICE Guidance
Jan 13, 2014
PDF 17.2 KB Add to Briefcase
View Summary pSivida Corp. Reports FDA Labeling Discussions for ILUVIEN® for DME; Advisory Committee Meeting No Longer Necessary
Dec 18, 2013
PDF 17.2 KB Add to Briefcase
View Summary pSivida Executives to Present at Two Upcoming Investor Conferences This Month
Dec 4, 2013
PDF 16.8 KB Add to Briefcase
View Summary pSivida Reports ILUVIEN® to Be Funded by UK's National Health Service for Treatment of Pseudophakic Chronic DME Patients Following Issuance of Final NICE Guidance
Dec 2, 2013
PDF 16.5 KB Add to Briefcase
View Summary pSivida Corp. Reports First Quarter 2014 Results
Nov 12, 2013
PDF 27.6 KB Add to Briefcase
View Summary pSivida Corp Announces First Quarter 2014 Financial Results Release Date and Conference Call Information
Nov 5, 2013
PDF 14.8 KB Add to Briefcase
View Summary pSivida Reports Complete Response Letter From FDA for ILUVIEN®
Oct 18, 2013
PDF 17.3 KB Add to Briefcase
View Summary pSivida Announces That U.K.'s NICE Recommends ILUVIEN® for Chronic Diabetic Macular Edema in Pseudophakic Eyes; NHS Reimbursement Expected to Follow
Sep 30, 2013
PDF 16.8 KB Add to Briefcase
View Summary pSivida to Present at 4th Annual Conference on Biosimilars & Biobetters
Sep 27, 2013
PDF 16.2 KB Add to Briefcase
Showing 81-100 of 269 Page: 1 2 3 4 5 6 7 8 9 ... 14  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida